Trimipramine
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Trimipramine
Description :
Trimipramine is a 5-HT receptor antagonist, with pKi binding values of 6.39, 8.10, 4.66 for 5-HT1C, 5-HT2 and 5-HT1A, respectively. Trimipramine is also a potent and selective inhibitor targeting human noradrenaline (hNAT), serotonin (hSERT) and organic cation transporters (hOCT1, hOCT2) with IC50 values of 4.99 μM, 2.11 μM, 3.72 μM, 8.00 μM, respectively. Trimipramine has vascular activity and anxiolytic efficacy[1][2][3].UNSPSC :
12352005Hazard Statement :
H225-H301+H311+H331-H370Target :
5-HT Receptor; BacterialType :
Reference compoundRelated Pathways :
Anti-infection; GPCR/G Protein; Neuronal SignalingApplications :
Neuroscience-NeuromodulationField of Research :
Neurological DiseaseAssay Protocol :
https://www.medchemexpress.com/trimipramine.htmlSolubility :
10 mM in DMSOSmiles :
CC(CN1C2=CC=CC=C2CCC3=C1C=CC=C3)CN(C)CMolecular Formula :
C20H26N2Molecular Weight :
294.43Precautions :
P210-P233-P240-P241-P242-P243-P260-P261-P264-P270-P271-P280-P302+P352-P303+P361+P353-P304+P340-P308+P311-P330-P361+P364-P370+P378-P403+P233-P403+P235-P405-P501References & Citations :
[1]Jenck F, et al. Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol. 1993 Feb 9. 231 (2) :223-9.|[2]Juorio AV, et al. The effects of chronic trimipramine treatment on biogenic amine metabolism and on dopamine D2, 5-HT2 and tryptamine binding sites in rat brain. Gen Pharmacol. 1990. 21 (5) :759-62. |[3]Haenisch B, et al. Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters. Psychopharmacology (Berl) . 2011 Sep. 217 (2) :289-95.Shipping Conditions :
Room temperatureScientific Category :
Reference compound1Clinical Information :
LaunchedIsoform :
5-HT1 Receptor; mLAG-3; α-1 microglobulinCAS Number :
[739-71-9]

